Mirion Q2 2026: Orders Jump, Margin Expands, and Guidance Remains Nuclear-Positive

Executive snapshot

• Second-quarter revenue: $266.8 million vs. $222.9 million in the year-ago period.
• GAAP net income: $8.1 million (down 4.7% from $8.5 million in Q2 2025).
• GAAP EPS: $0.03 per share; Adjusted EPS: $0.12 per share (adjusted for stock-based compensation).
• Adjusted EBITDA: $65.3 million (up 27.5% from $51.2 million in the year-ago period).
• Orders: $229 million excluding Paragon & Certrec acquisitions; $291 million including them—up about 40% year over year.
• Guidance: Mirion reaffirms 2026 targets for total revenue growth, organic growth, Adjusted EBITDA, Adjusted Free Cash Flow, and Adjusted EPS.

Financial highlights in context

The quarter underscored a classic “signal versus noise” moment for Mirion (NYSE: MIR): the headline GAAP profitability was modestly softer on a per-share basis, but the combination of stronger revenue, margin expansion, and a notably higher backlog hints at sustainable earnings leverage. Management framed the results as reflective of margin expansion across operating segments and a robust pipeline of large opportunity orders—barring what the company described as acquisition-driven offsets in the period.

Notably, Adjusted EBITDA rose meaningfully to $65.3 million, a testament to better cost control and a more favorable mix as the company integrates recent acquisitions. The press release notes that the Adjusted EPS figure includes stock-based compensation, a reminder that non-cash costs can blur the underlying profitability narrative analysts often chase.

Operations, acquisitions, and mix

The company’s second-quarter orders tell a dual story. Excluding Paragon and Certrec, orders were $229 million; including those acquisitions, orders totaled $291 million, marking a 40% uplift versus the prior year. Management emphasized that Certrec and Paragon augment Mirion’s capability to capitalize on growing nuclear power opportunities in North America, while also supporting the global footprint in medical, defense, and research end markets. The acquisitions appear to have turbocharged the top line, even as integration work continues.

On the revenue mix, Mirion highlighted margin expansion across its operating segments—a positive sign for backlog conversion and operating leverage as demand flows into the back half of the year. The tone suggests a company that is leveraging its enlarged addressable market without sacrificing cash generation or balance sheet discipline.

Guidance and outlook

For 2026, Mirion reaffirmed its full-year targets: total revenue growth in the high-teens to mid-20s range, specifically a revenue growth of about 22.0% to 24.0% and organic revenue growth of roughly 5.0% to 7.0%. The company also maintained its targets for Adjusted EBITDA, Adjusted Free Cash Flow, and Adjusted EPS, signaling confidence in the operational trajectory even after incorporating the contributions from Certrec and Paragon.

The emphasis on a steady revenue forecast for the year, coupled with margin and cash-flow ambitions, points to a durable growth thesis. Management highlighted that margin expansion is supported by a stronger backlog and a diversified mix of end markets, with acquisitions fueling scale rather than merely acting as catalysts for short-term upside.

Implications for Mirion and sector peers

Mirion’s Q2 narrative — stronger top-line momentum, meaningful orders growth, and a disciplined approach to profitability — could reverberate across the radiation-detection and nuclear-solutions space. For peers in the sector, the message is twofold: (1) scale matters, especially when coupled with strategic acquisitions that extend reach into attractive geographies and market segments; (2) disciplined cost management and a clear path to Adjusted EBITDA and Adjusted EPS growth can help normalize valuation versus more cyclical industrial peers.

Analysts will be watching whether the favorable orders trend sustains into the back half of 2026 and whether FX and acquisitive synergies continue to support margins. If the backlog continues to grow and the company maintains its revenue forecast, MIR could attract multiple on growth, particularly as energy market dynamics keep demand for nuclear-detection, measurement, and monitoring solutions resilient. The larger question for the sector remains: how quickly will customers translate orders into revenue and how will supply chains react as the mix shifts toward complex, integrated solutions?

Management commentary and interpretation

CEO Thomas Logan framed the results as evidence of an expanding opportunity set. He pointed to margin expansion across operating segments, increased adjusted free cash flow, and ongoing orders and backlog growth as signs of Mirion's leverage in a market with durable demand. The acquisitions of Certrec and Paragon are positioned as accelerants rather than merely tailwinds, suggesting the company intends to lean into growth opportunities rather than optimize for a single-line defense.

Bottom line

Mirion’s Q2 2026 results deliver a nuanced narrative: solid revenue growth and a robust orders pipeline, powered in part by strategic acquisitions, support a constructive view of the year ahead. While GAAP profitability offered a modest step back, the structural improvements in Adjusted EBITDA and cash flow, combined with a reaffirmed revenue forecast, imply a company that is managing the shift toward higher-margin, higher-value projects with discipline. For investors watching the MIR ticker, the signal is clear enough: the core growth engine is not just humming—it's expanding, with the caveat that earnings visibility remains tethered to integration milestones and the pace of backlog conversion.